The Vera Bradley Foundation Center is home to our multidisciplinary team of research physicians and laboratory scientists who are pushing the boundaries of modern medicine to spread hope and find a cure.
We’re learning how and why breast cancer develops, how it behaves at different stages of life, and how it uniquely affects different racial and ethnic groups.
We’re creating new technologies, crafting highly customized therapies, and helping women avoid the life-altering side effects that often result from standard treatment.
Because we know that #ResearchCuresCancer.
Our research team is relentlessly pursuing critical advancements that have and will continue to change the face of breast cancer forever.
Ruth Cook — Chair, Vera Bradley Foundation Board of Directors
Our researchers are turning their science into solutions for those at risk for breast cancer, those who have been diagnosed with the disease, and those who are survivors.
Listen to what we have to say about the incredible advances we’re making in diagnosing and treating even the toughest breast cancer tumors—then read more about the extraordinary generosity of the Vera Bradley Foundation.
100 Voices of Hope is a grassroots effort to raise $100,000 every year to end metastatic breast cancer through research.
Vera Bradley Center faculty have used their 100 Voices of Hope awards to study everything from epigenetics and proteomics to chemotherapy resistance and racial disparities.
Since 2004, more than 1,300 discoveries have been published in peer-reviewed journals by IU breast cancer researchers.
If you follow the field of breast cancer research, you probably already know the name Bryan P. Schneider, MD.
As the Vera Bradley Foundation Professor of Oncology, Dr. Schneider has been making headlines with the PERSEVERE study—a $12 million nationwide clinical trial testing how to treat patients with triple negative breast cancer based on their own unique genetic data.
He’s also leading another national clinical trial, known as EAZ171, that analyzes racial disparities in taxane-induced peripheral neuropathy. It’s the first clinical trial to specifically recruit Black women, a fact the Vera Bradley Foundation Center team is determined to change.
And those are just two of the major projects that have made Dr. Schneider a renowned and in-demand collaborator in nearly every area of breast cancer research. He’ll tell you there’s more coming soon—and more after that.
Donor support is crucial to advancing discoveries that will have the most meaningful impact on women’s lives. You can help us make it happen.
Vera Bradley Foundation Center for Breast Cancer Research
535 Barnhill Drive
Indianapolis, IN 46202
